Midas Management’s Gilead Sciences GILD Stock Holding History

Midas Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-30,500	Closed	-$2.16M	–	122
2018 Q2	$2.16M	Hold	30,500	–	–	1.03%	50
2018 Q1	$2.3M	Hold	30,500	–	–	1.08%	46
2017 Q4	$2.19M	Hold	30,500	–	–	0.87%	55
2017 Q3	$2.47M	Hold	30,500	–	–	1.3%	26
2017 Q2	$2.16M	Hold	30,500	–	–	1.15%	37
2017 Q1	$2.07M	Sell	30,500 -2,500	-8%	-$176K	1.09%	36
2016 Q4	$2.36M	Buy	33,000 +20,430	+163%	+$1.52M	1.11%	16
2016 Q3	$995K	Hold	12,570	–	–	0.61%	79
2016 Q2	$1.05M	Hold	12,570	–	–	0.59%	82
2016 Q1	$1.16M	Hold	12,570	–	–	0.6%	82
2015 Q4	$1.27M	Buy	+12,570	New	+$1.31M	0.76%	64

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Midas Management's GILD Position: Q3 2018 in Review

Midas Management sold out of Gilead Sciences (GILD) in Q3 2018, closing a stake of 30,500 shares — an estimated $2.16M sold.

Midas Management first reported a position in GILD in Q4 2015 and held it in 11 quarters. The position peaked at $2.47M in Q3 2017. 1,527 funds tracked by Wall St. Rank hold GILD as of Q3 2018.

Midas Management reported no remaining Gilead Sciences position as of Q3 2018 after selling out during the quarter.
Midas Management sold 30,500 Gilead Sciences shares in Q3 2018, an estimated $2.16M.
Midas Management first reported a position in Gilead Sciences in Q4 2015 and held it in 11 quarters.
Midas Management's Gilead Sciences position peaked at $2.47M in Q3 2017.
1,527 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2018.

Based on Midas Management's 13F filing for Q3 2018, filed 9 Oct 2018.